These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5319032)

  • 1. Patient report of significant life situation events (methodological implications for outpatient drug evaluation).
    Lipman RS; Hammer HM; Bernardes JF; Park LC; Cole JO
    Dis Nerv Syst; 1965 Sep; 26(9):586-91. PubMed ID: 5319032
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication, anxiety reduction and patient report of significant life situation events.
    Lipman RS; Covi L; Derogatis LR; Rickels K; Uhlenhuth EH
    Dis Nerv Syst; 1971 Apr; 32(4):240-4. PubMed ID: 4932964
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.
    Sterlin C; Ban TA; Lehmann HE; Jarrold L
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):195-200. PubMed ID: 4985940
    [No Abstract]   [Full Text] [Related]  

  • 4. Prazepam in the treatment of psychoneurotic outpatients: a brief report.
    Silver D; Ban TA; Kristof FE; Saxena BM; Bennett J
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):596-8. PubMed ID: 4981302
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential drug effects in neurotic depression.
    Rickels K; Hesbacher P; Downing RW
    Dis Nerv Syst; 1970 Jul; 31(7):468-75. PubMed ID: 4918448
    [No Abstract]   [Full Text] [Related]  

  • 6. Butabarbital sodium and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study.
    Rickels K; Clark EL; Etezady MH; Sachs T; Sapra RK; Yee R
    Clin Pharmacol Ther; 1970; 11(4):538-50. PubMed ID: 4913869
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrosleep: a double-blind clinical study.
    Rosenthal SH
    Biol Psychiatry; 1972 Apr; 4(2):179-85. PubMed ID: 4554818
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical trial of EXP 338 in the treatment of a neurotic population.
    Claghorn JL; Schoolar JC
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):279-81. PubMed ID: 4969833
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug- and placebo-treated neurotic outpatients. Pretreatment levels of manifest anxiety, clinical improvement, and side reactions.
    Rickels K; Downing RW
    Arch Gen Psychiatry; 1967 Mar; 16(3):269-72. PubMed ID: 6021472
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of mesoridazine and chlordiazepoxide in psychoneurotic patients.
    Goldstein BJ; Slater V; Miller J; Jones E; Olsen P; Shea GM
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):657-62. PubMed ID: 4982299
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance and improvement in drug-treated and placebo-treated neurotic outpatients.
    Rickels K; Downing R
    Arch Gen Psychiatry; 1966 Jun; 14(6):631-3. PubMed ID: 5327339
    [No Abstract]   [Full Text] [Related]  

  • 12. Doxepin in the treatment of psychoneurotic patients.
    Beaubien J; Ban TA; Lehman HE; Jarrold L
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):192-4. PubMed ID: 4985939
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of doxepin and chlordiazepoxide in the therapy of anxiety.
    Simeon J; Spero M; Nikolovski OT; Fink M
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):201-12. PubMed ID: 4985941
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of psychotropic drug therapy in chronic hyperventilation syndrome: intensive study design.
    Aronson PR
    J New Drugs; 1966; 6(5):305-7. PubMed ID: 5339422
    [No Abstract]   [Full Text] [Related]  

  • 15. Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.
    Covi L; Lipman RS; Pattison JH; Derogatis LR; Uhlenhuth EH
    Acta Psychiatr Scand; 1973; 49(1):51-64. PubMed ID: 4572168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Impotentia erectionis--therapeutic attempt using bamethan sulfate, synephrine, and coffeinum purum].
    Rytter M
    Z Haut Geschlechtskr; 1973 Jun; 48(12):481-6. PubMed ID: 4147812
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlordiazepoxide and hostility in anxious outpatients.
    Rickels K; Downing RW
    Am J Psychiatry; 1974 Apr; 131(4):442-4. PubMed ID: 4592554
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxepin in the treatment of psychoneurotic inpatients.
    Sterlin C; Oliveros R; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1971 Sep; 13(9):580-3. PubMed ID: 5000460
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlordiazepoxide in the treatment of patients with "activated EEG's".
    Monroe RR; Dale R
    Dis Nerv Syst; 1967 Jun; 28(6):390-6. PubMed ID: 5340423
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlordiazepoxide in anxiety states.
    Practitioner; 1965 Nov; 195(169):689-95. PubMed ID: 5321367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.